1/ $AMLX Upcoming IPO(Feb 7th) Amylyx pharmaceuticals has developed a drug(AMX0035) for the treatment of ALS. They believe it is the first to both slow decline and lengthen the life of ALS patients. We believe the drug is inert and will fail its upcoming Phase 3 Phoenix trial.

Estimated and actual monetization levels for $FB, $SNAP, $TWTR, TikTok and Instagram

-71.6% is EF Hutton's average non-SPAC IPO performance since last November. Makes the new SPAC vehicle under their name worth watching.... EF Hutton Acquisition Corporation I (NASDAQ:EFHT) $REBN $TGL $TCBP $BGXX $GFAI $HOUR $STRN $PIK $EFHT

$GRVY: Some comp numbers of Korean game development companies. All listed on Korean exchanges other than GRVY which is listed on Nasdaq.

$GRVY Historical revenue for each of their games and game categories from disclosures. Origin has been the main contributor in the most recent quarter.

$AMLX Our initial short report thread from beginning of 2022. Finally proving no significant difference with placebo and failing to meet all secondary endpoints: x.com/SumerianRsch/s…